A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

Exclusion Criteria

• Use of lipid-lowering medication for more than 3 months within the previous 12
• months. Longer periods of treatment are not permitted because of the potential
• effects of such therapy on coronary atherosclerosis. Subjects receiving treatment
• with a lipid-lowering medication within the past 4 weeks require a 4-week wash-out period following which a baseline lipid profile will be taken at visit 2.
• Clinically significant heart disease which, in the opinion of the Principal
• Investigator (or designee), is likely to require coronary bypass surgery, cardiac
• transplantation, surgical repair and/or replacement during the course of the study.
• -